SUPPLY CHAIN
“PHARMA COMPANIES ARE VULNERABLE TO THE EFFECTS OF CLIMATE CHANGE . WE ARE ALREADY SEEING IT DIRECTLY IMPACT SUPPLY CHAIN CONTINUITY ”
KATE RODGER HEAD OF CUSTOMER SUCCESS , CERVEST
not without a carbon footprint . Yet , in the smartphone era , a simple QR code on the medicine ’ s packaging can explain everything to the patient in their language – this is one of the many steps the pharmaceutical industry can take to become more sustainable .
Rodger ’ s message to the pharma industry is that it must recognise how vulnerable it is to the effects of climate change .
“ We are already seeing climate change directly impact manufacturing operations , supply chain continuity and resource availability ,” says Rodger . “ Overlooking the impact of physical climate risk at the asset level may lead , at best , to expensive shortterm adaptation measures and , at worst , stranded assets , operational disruption and losing out to competitors better placed to scale operations . To meet the growing demand and market opportunity , pharma companies must invest now to pinpoint risk , climate-align decisions , and build asset resilience .”
In the fight against man-made climate change and the push towards clean energy , expensive short-term adaptation will lead to long-term prosperity . Climate intelligence can make this possible . healthcare-digital . com 85